MAZE Earnings Date: Nov 5, 2026 (Estimated) — Maze Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology
Updated
When is MAZE's next earnings date?
Maze Therapeutics, Inc. (MAZE) is expected to report Q3 2026 earnings on Thursday, November 5, 2026 at 4:00 PM ET (after market close); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.76 on revenue of $333,333.
How did MAZE do in its last earnings report?
In its most recent report on Aug 12, 2026, Maze Therapeutics, Inc. posted EPS of -$0.76 versus the -$0.72 estimate, a miss of 5.9%. The stock's 1-day post-earnings move was +1.3%.
How much does MAZE stock move after earnings?
MAZE beat EPS estimates in 4 of its last 6 reported quarters. Over the last 6 reports the stock moved an average of 7.7% (up or down) in the day after earnings.
About Maze Therapeutics, Inc.
Maze Therapeutics, Inc., a clinical stage biopharmaceutical company, develops small molecule precision medicines for the treatment of kidney and metabolic diseases in the United States. Its lead programs include MZE829, an oral small molecule inhibitor of apolipoprotein L1, or APOL1, which is in phase II clinical trial for the treatment of patients with APOL1 kidney disease; and MZE782, an oral small molecule inhibitor that is in phase II ready clinical trial for the treatment of phenylketonuria and chronic kidney disease. The company also develops MZE001, an investigational oral small molecule inhibitor of muscle-specific glycogen synthase clinical program for the treatment of Pompe disease. It has a license agreement with Trace Neuroscience, Inc. to discovery research program targets UNC13A; the Shionogi & Co., Ltd to research, develop, manufacture, and commercialize MZE001; and Neurocrine Biosciences, Inc. to discover research program that targets ATXN2. The company was formerly known as Modulus Therapeutics, Inc. and changed its name to Maze Therapeutics, Inc. in September 2018. The company was incorporated in 2017 and is based in South San Francisco, California.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-12 | -0.72 | -0.76 | -5.95% | — | ❌ Miss | +1.30% | +6.66% | -9.12% | |
| 2026-08-11 | Q2 2026 | -0.71 | -0.76 | -7.04% | $0 | ❌ Miss | +0.81% | +6.66% | -9.12% |
| 2026-05-12 | Q1 2026 | -0.59 | -0.45 | +23.73% | $20.0M | ✅ Beat | +4.58% | -5.12% | -6.56% |
| 2026-03-25 | Q4 2025 | -0.71 | -0.65 | +8.45% | $0 | ✅ Beat | -35.24% | -39.08% | -46.92% |
| 2025-11-06 | Q3 2025 | -0.71 | -0.66 | +7.04% | $0 | ✅ Beat | -3.48% | +7.46% | +39.93% |
| 2025-08-12 | Q2 2025 | -1.01 | -0.77 | +16.30% | $0 | ✅ Beat | -1.02% | -2.11% | +80.49% |
Showing last 6 quarters.